| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |